1 2 3 4 5 6 7 8 9 10 11

читать далее ... ngs С. J. A. M., Dammers R., Rensma P. L. et al. Arterial wall properties in patients with renal failure. Am. J. Kidney Dis. 2002; 39: 1206-1212. 38. Bcnetos A., Waeber В., Izzo J. et al. Influence of age, risk factors and cardiovascular and renal disease on arterial stiffness: clinical applications. Am. Hypertens. 2002; 15 (12): 1101— 1108. 39. Amann K., Wolf В., Nichols С. et al. Aortic changes in experimental renal failure: Hyperplasia or hypertrophy of smooth muscle cells? Hypertension 1997; 29: 770—775. 40. Kawagishi Т., Nishizawa Y., Konishi T. et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int. 1995; 48: 820-826. 41. Cannata-Andia J. В., Rodriguez-Garcia M. Hyperphosphatae mia as a cardiovascular risk factor — how to manage the prob lem. Nephrol. Dial. Transplant. 2002; 17 (suppl. II): 16—19. 42. Goodnien W. G., Golding J., Kuizon B. et al. Coronary artery calcification in young adults with end-stage renal disease who undergoing dialysis. N. Engl. J. Med. 2000; (18): 1478-1483. 43. Guerin A. P., London G. M., Marchais S. J., Metivier F. Arterial stiffness and vascular calcification in end-stage renal disease. Nephrol. Dial. Transplant. 2003; 15: 1014—1026. 44. Barenbrock M., Hausberg M., Kosch M. et al. A longitudinal study of vessel wall properties in normotensive and hypertensive renal transplantant recipients. J. Hiuti. Hypertens. 1998; 12: 707-711. 45. Raj D. S. С. Advanced glycation end products: A nephrologists perspective. Am. J. Kidney Dis. 2000; 35: 365—380. 46. Vanholder R., Glorieux G., Lameire N. Uraemic toxins and cardiovascular disease. Nephrol. Dial. Transplant. 2003; 18: 463— 466. 47. Cooke J. P. Does ADMA cause endothelial dysfunction? Arterioscler. Thromb. Vase. Biol. 2000; 20: 2032—2037. 48. Moustapha A., Naso A., Nahlawi M. et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 1998; 97: 138—141. 49. London G. M., Pannier В., Guerin A. P. et al. Alteration of left ventricular hypertrophy and survival of patients receiving hemodialysis: follow-up of an interventional study. J. Am. Soc. Nephrol. 2001; 12: 2759-2767. 50. Guerin A. P., BIacher J., Pannier B. et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439. 51. Locatelli F., Bommer J., London G. M. et al. Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. Nephrol. Dial. Transplant. 2001; 16: 459—468. 52. Galle J. Oxidative stress in chronic renal failure. Nephrol. Dial. Transplant. 2001; 16: 2135-2137.Источник: Кутырина И.М. и др. Клиническая медицина. 2005. №2. С.16-21